Hirayama disease

Hirayama Disease Hirayama disease, also known as monomelic amyotrophy, is a rare neurological condition characterized by muscle weakness and atrophy in the upper limbs, particularly affecting young males. This condition is named after Dr. Keizo Hirayama, who first described it in 1959.

Clinical Features

Hirayama disease typically presents in the late teens or early twenties. The main clinical features include:

• Muscle Weakness and Atrophy: Primarily affects the distal muscles of the hand and forearm, leading to a characteristic "oblique amyotrophy."
• Unilateral or Asymmetric Involvement: Often affects one side more than the other.
• Cold Sensitivity: Symptoms may worsen in cold environments.
• No Sensory Loss: Unlike other neurological conditions, Hirayama disease does not typically involve sensory deficits.

Pathophysiology

The pathophysiology of Hirayama disease is not completely understood, but it is believed to involve a dynamic compression of the cervical spinal cord during neck flexion. This compression leads to ischemia and subsequent motor neuron damage in the anterior horn of the spinal cord.

Diagnosis

Diagnosis of Hirayama disease is primarily clinical, supported by imaging studies such as MRI. Key diagnostic features include:

• MRI Findings: Flexion MRI of the cervical spine may show forward displacement of the posterior dural sac and flattening of the spinal cord.
• Electromyography (EMG): May show chronic denervation in the affected muscles.

Treatment

There is no cure for Hirayama disease, but treatment focuses on managing symptoms and preventing progression. Options include:

• Cervical Collar: To prevent neck flexion and reduce spinal cord compression.
• Physical Therapy: To maintain muscle strength and function.
• Surgical Intervention: In some cases, surgery may be considered to stabilize the cervical spine.

Prognosis

The prognosis for Hirayama disease is generally favorable, with many patients experiencing stabilization of symptoms after a few years. However, some degree of muscle weakness and atrophy may persist.

Epidemiology

Hirayama disease is more common in Asian populations, particularly in Japan and India. It predominantly affects males, with a male-to-female ratio of approximately 20:1.

See Also

• Monomelic Amyotrophy
• Cervical Myelopathy
• Motor Neuron Disease
• Hirayama, K. (1959). "Juvenile muscular atrophy of unilateral upper extremity (Hirayama disease)." *Neurology*.
• Misra, U. K., & Kalita, J. (2007). "Hirayama disease." *Journal of Neurology*.

NIH genetic and rare disease info

• NIH info on Hirayama disease

Hirayama disease is a rare disease.